Wockhardt sets up $40-million antibiotic manufacturing plant in Jafza, Dubai
Wockhardt, an India-based pharmaceutical company, launched a new facility at Dubai’s Jebel Ali Free Zone (Jafza) on Sunday, marking its entry into... Read More
Wockhardt’s Ankleshwar plant received USFDA warning letter over data integrity issues
Posted on05 Jan 2017
Tags483, 483 OBSERVATION, 483 observations, FORM 483, form 483 observation, USFDA warning letter, Wockhardt
Comments0
US Food and Drug Administration (USFDA) has issued a warning letter to Wockhardt’s Ankleshwar plant for data integrity issues, destruction of records... Read More